Global Laboratory Developed Tests (LDT) Market Growth (Status and Outlook) 2023-2029

Global Laboratory Developed Tests (LDT) Market Growth (Status and Outlook) 2023-2029

LPI (LP Information)' newest research report, the “Laboratory Developed Tests (LDT) Industry Forecast” looks at past sales and reviews total world Laboratory Developed Tests (LDT) sales in 2022, providing a comprehensive analysis by region and market sector of projected Laboratory Developed Tests (LDT) sales for 2023 through 2029. With Laboratory Developed Tests (LDT) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Laboratory Developed Tests (LDT) industry.

This Insight Report provides a comprehensive analysis of the global Laboratory Developed Tests (LDT) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Laboratory Developed Tests (LDT) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Laboratory Developed Tests (LDT) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Laboratory Developed Tests (LDT) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Laboratory Developed Tests (LDT).

The global Laboratory Developed Tests (LDT) market size is projected to grow from US$ 4466.7 million in 2022 to US$ 8499.7 million in 2029; it is expected to grow at a CAGR of 9.6% from 2023 to 2029.

Global top 5 players of Laboratory Developed Tests (LDT) occupied for 53% of the market, including Quest Diagnostics, Thermo Fisher, Waters Corporation, Roche, Illumina. North America is the largest market of Laboratory Developed Tests (LDT), holding a share over 47%. Then Europe takes 25%. In terms of type, Molecular Diagnostics shares over 31% of the market, while Immunology shares 25%. In terms of application, Hospitals Laboratory shares the largest percent of nearly 56%.

This report presents a comprehensive overview, market shares, and growth opportunities of Laboratory Developed Tests (LDT) market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Clinical Biochemistry
Hematology
Immunology
Molecular Diagnostics
Other

Segmentation by application
Hospitals Laboratory
Clinical Research Organizations
Academic Institutes
Specialty Diagnostic Centers
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Quest Diagnostics
Thermo Fisher
Waters Corporation
Roche
Illumina
Qiagen
Eurofins
Guardant Health
Adaptive Biotechnologies
Biodesix
Berry Oncology
Genetron Health

Please note: The report will take approximately 2 business days to prepare and deliver.